Journal article
Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR Insights From the FRAILTY-AVR Study
Abstract
OBJECTIVES: The aim of this study was to examine the value of frailty to predict in-hospital major bleeding and determine its impact on mid-term mortality following transcatheter (TAVR) or surgical (SAVR) aortic valve replacement.
BACKGROUND: Bleeding complications are harbingers of mortality and major morbidity in patients undergoing TAVR or SAVR. Despite the high prevalence of frailty in this population, little is known about its effects on …
Authors
Bendayan M; Messas N; Perrault LP; Asgar AW; Lauck S; Kim DH; Arora RC; Langlois Y; Piazza N; Martucci G
Journal
JACC Cardiovascular Interventions, Vol. 13, No. 9, pp. 1058–1068
Publisher
Elsevier
Publication Date
5 2020
DOI
10.1016/j.jcin.2020.01.238
ISSN
1936-8798
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Age FactorsAgedAged, 80 and overAortic Valve StenosisCanadaErythrocyte TransfusionFemaleFrail ElderlyFrailtyFranceGeriatric AssessmentHeart Valve Prosthesis ImplantationHumansMalePostoperative HemorrhageProspective StudiesRisk AssessmentRisk FactorsTime FactorsTranscatheter Aortic Valve ReplacementTreatment OutcomeUnited States